secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-10-15T20:15:36+00:00
Accession:  0001493152-26-047242
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4.1-flash:cloud@v2

Co-Diagnostics abandons annual meeting after 4 failed quorum attempts; plans special meeting
--------------------------------------------------------------------------------

- Annual Meeting held September 3, 2026 lacked a quorum; reconvened September 24, September 30 and October 14, 2026 with no quorum on any date.
- Company determined not to adjourn again; no business was transacted and none of the meeting's proposals were voted on.
- Co-Diagnostics intends to seek stockholder approval of those proposals at a special meeting on a future, still-unannounced date.
- Date, time and location of any special meeting will be disclosed in proxy materials filed with the SEC and sent to stockholders.
- Signed by CEO Dwight Egan on October 15, 2026; common stock (CODX) trades on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226047242/0001493152-26-047242-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226047242/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-047242

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer